GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Issuance of Stock

Sinopharm Group Co (HKSE:01099) Issuance of Stock : HK$0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Issuance of Stock?

Sinopharm Group Co's Issuance of Stock for the six months ended in Dec. 2024 was HK$0 Mil.

Sinopharm Group Co's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0 Mil.


Sinopharm Group Co Issuance of Stock Historical Data

The historical data trend for Sinopharm Group Co's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Issuance of Stock Chart

Sinopharm Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,268.03 - - - -

Sinopharm Group Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinopharm Group Co Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Group Co Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Group Co Business Description

Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Executives
Citic Securities Company Limited 2201 Interest of corporation controlled by you
Zhong Xin Zheng Quan Yun Fan Dan Yi Zi Chan Guan Li Ji Hua 2501 Other
Zhong Xin Zheng Quan Zi Chan Guan Li You Xian Gong Si 2102 Investment manager
Lazard Asset Management Llc 2102 Investment manager
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Fmr Llc 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you

Sinopharm Group Co Headlines

No Headlines